Comparison

PD 123319 (ditrifluoroacetate) European Partner

Item no. HY-10259A-5mg
Manufacturer MedChem Express
CASRN 136676-91-0
Amount 5 mg
Quantity options 10 mM/1 mL 10 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 99.82
Citations [1]Blankley CJ, et al. Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype. J Med Chem. 1991 Nov;34(11):3248-60.|[2]Boulay G, et al. Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa. Mol Pharmacol. 1992 Apr;41(4):809-15|[3]Estrup TM, et al. No effect of angiotensin II AT(2)-receptor antagonist PD 123319 on cerebral blood flow autoregulation. J Renin Angiotensin Aldosterone Syst. 2001 Sep;2(3):188-92.|[4]Brillante DG, et al. Effects of intravenous PD 123319 on haemodynamic and arterial stiffness indices in healthy volunteers. J Renin Angiotensin Aldosterone Syst. 2005 Sep;6(2):102-6.
FASEB J. 2018 Sep;32(9):5051-5062.|Acta Pharmacol Sin. 2024 Mar 15.|FASEB J. 2019 May;33(5):6254-6268. |Int Immunopharmacol. 2022 Jun 17;110:108921.|J Exp Med. 2022 Mar 7;219(3):e20211001.|Redox Biol. October 2021, 102115.|Rep Biochem Mol Biol. 2021 Aug.|Rep Biochem Mol Biol. 2021 Jul;10(2):314-326.|SSRN. 13 Apr 2022.
Smiles FC(F)(C(O)=O)F.FC(F)(C(O)=O)F.O=C([C@@H]1CC2=C(N=CN2CC3=CC=C(N(C)C)C(C)=C3)CN1C(C(C4=CC=CC=C4)C5=CC=CC=C5)=O)O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 136676-91-0
Shipping Condition Room temperature
Available
Manufacturer - Type
Reference compound
Manufacturer - Applications
COVID-19-immunoregulation
Manufacturer - Targets
Angiotensin Receptor
Shipping Temperature
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Molecular Weight
736.66
Product Description
PD 123319 (ditrifluoroacetate) is a potent, selective AT2 angiotensin II receptor antagonist with IC50 of 34 nM.
Manufacturer - Research Area
Cardiovascular Disease; Endocrinology
Solubility
H2O: ≥ 36 mg/mL
Manufacturer - Pathway
GPCR/G Protein
Isoform
AT2 Receptor
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close